Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 17-Mar-22 5:50 PM View:  | Revance Therapeutics, Inc. (RVNC) | 15-Mar-22 | Payment of Exercise | 1,372 | $15.79 | $21,663.90 | (< 1%) 571.38K to 570.0K | 2% |
| 06-Dec-21 8:34 PM View: | Revance Therapeutics, Inc. (RVNC) | 03-Dec-21 | Market Purchase | 30,000 | $14.43 | $432,876.00 | 6% 541.38K to 571.38K | 1% |
| 17-Aug-21 6:20 PM View: | Revance Therapeutics, Inc. (RVNC) | 16-Aug-21 | Market Sale (Planned) | 9,364 | $26.34 | $246,659.00 | (2%) 550.74K to 541.38K | (< 1%) |
| 17-Aug-21 6:20 PM View: | Revance Therapeutics, Inc. (RVNC) | 15-Aug-21 | Payment of Exercise | 4,949 | $26.02 | $128,773.00 | (< 1%) 555.69K to 550.74K | (2%) |
| 30-Jul-21 8:57 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jul-21 | Market Sale | 20,000 | $30.15 | $603,000.00 | (3%) 610.02K to 590.02K | 3% |
| 30-Jul-21 8:57 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Jul-21 | Market Sale (Planned) | 34,332 | $30.00 | $1,029,960.00 | (6%) 590.02K to 555.69K | 3% |
| 28-Jul-21 9:48 PM View: | Revance Therapeutics, Inc. (RVNC) | 26-Jul-21 | Market Sale (Planned) | 55,382 | $29.72 | $1,645,950.00 | (8%) 665.4K to 610.02K | 3% |
| 06-Apr-21 7:41 PM View: | Revance Therapeutics, Inc. (RVNC) | 05-Apr-21 | Market Sale (Planned) | 2 | $28.28 | $56.56 | (< 1%) 665.4K to 665.4K | (< 1%) |
| 05-Mar-21 8:10 PM View: | Revance Therapeutics, Inc. (RVNC) | 04-Mar-21 | Market Sale (Planned) | 33,119 | $25.43 | $842,216.00 | (5%) 698.52K to 665.4K | (1%) |
| 04-Feb-21 9:16 PM View: | Revance Therapeutics, Inc. (RVNC) | 02-Feb-21 | Grant | 11,905 | -- | -- | 2% 686.62K to 698.52K | |
| 03-Feb-21 8:13 PM View: | Revance Therapeutics, Inc. (RVNC) | 01-Feb-21 | Market Sale (Planned) | 33,119 | $25.95 | $859,438.00 | (5%) 719.74K to 686.62K | (8%) |
| 04-Jan-21 8:01 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Dec-20 | Market Sale (Planned) | 33,119 | $27.82 | $921,212.00 | (4%) 752.86K to 719.74K | (2%) |
| 02-Dec-20 8:55 PM View: | Revance Therapeutics, Inc. (RVNC) | 30-Nov-20 | Market Sale (Planned) | 33,119 | $23.85 | $789,888.00 | (4%) 785.98K to 752.86K | (16%) |
| 30-Oct-20 8:24 PM View: | Revance Therapeutics, Inc. (RVNC) | 29-Oct-20 | Market Sale (Planned) | 33,119 | $26.15 | $865,949.00 | (4%) 819.1K to 785.98K | (5%) |
| 30-Sep-20 9:21 PM View: | Revance Therapeutics, Inc. (RVNC) | 28-Sep-20 | Market Sale (Planned) | 33,119 | $26.18 | $867,055.00 | (4%) 852.21K to 819.1K | (5%) |
| 27-Jul-20 7:57 PM View: | Revance Therapeutics, Inc. (RVNC) | 23-Jul-20 | Grant | 667,292 | -- | -- | 255% 261.45K to 928.75K |